NewsMV

Profound Medical forecasts Q3 revenue between $9.8M and $10M

10/8/2026

Preliminary unaudited results for Profound Medical Corp.

(NASDAQ: PROF; TSX: PRN) indicate third-quarter 2026 revenue will land between $9.8 million and $10.0 million, a range the company stated exceeds the Bloomberg mean analyst consensus of $6.78 million by approximately 45% to 47%.

The figures, announced on October 7, 2026, are expected to mark a record for the company's quarterly revenue.

Profound projected year-over-year growth of approximately 85% to 89% compared with $5.3 million in the third quarter of 2025.